1,093 results on '"Livermore, David M."'
Search Results
2. Regional variations in antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli in India: Findings of a multicentric study highlighting the importance of local antibiograms
3. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group
4. AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications
5. Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance
6. Fosfomicina trometamolo nel trattamento d delle infezioni acute del tratto urinario inferiore in donne in gravidanza e non nell'era della gestione antimicrobica: un'opinione consensuale di un gruppo di esperti internazionali.
7. The Bacterial Burden of Worn Face Masks – Observational Research and Literature Review
8. UK clinicians’ attitudes towards the application of molecular diagnostics to guide antibiotic use in ICU patients with pneumonias: a quantitative study
9. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study
10. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection
11. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
12. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group
13. UK clinicians' attitudes towards the application of molecular diagnostics to guide antibiotic use in ICU patients with pneumonias: a quantitative study.
14. Fosfomycin trometamol for the treatment of acute lower urinary tract infections in pregnant and non-pregnant women in an age of antimicrobial stewardship: a consensus opinion of an international expert panel.
15. Activity of aztreonam/avibactam against metallo-β-Lactamase-producing Enterobacterales from the UK: impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli
16. Antimicrobial Susceptibility Profile of Community-Acquired Uropathogenic Escherichia Coli Across India: A Multicentric Study Promoting Diagnostic Stewardship in the Management of UTI
17. Activity of ertapenem/zidebactam (WCK 6777) against problem Enterobacterales
18. OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
19. In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK
20. Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococci
21. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
22. Early (2008–2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK
23. A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus
24. Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?
25. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study
26. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
27. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011
28. In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci
29. Efficacies of calcium–EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 β-lactamase
30. Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance
31. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study
32. THERAPEUTICS: Carbapenem antibiotics for serious infections
33. Fourteen years in resistance
34. Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilution
35. COVID-19 vaccination and HIV-1 acquisition
36. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiologicalinvestigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study
37. A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients
38. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
39. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae
40. The emerging NDM carbapenemases
41. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
42. Bacterial Resistance to Carbapenems
43. Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance
44. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study
45. Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria
46. KPC enzymes in the UK: an analysis of the first 160 cases outside the North-West region
47. Genetic environment of metallo-β-lactamase genes in Pseudomonas aeruginosa isolates from the UK
48. Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint
49. Mutation frequency in antibiotic-resistant and -susceptible isolates of Streptococcus pneumoniae
50. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.